Malaysian (KLSE) Pharmaceuticals & Biotech Dividend Stocks

UPDATED May 18, 2024

Discover Malaysian Pharmaceuticals & Biotech High Yield Dividend Stocks that are on the KLSE and sorted by Dividend Yield. An upper limit of 20% is in place to filter out stocks with potentially unsustainable dividends. All companies with high dividend yields (above 5%) should be researched for sustainability. For more options please click on ‘Advanced Filters’.

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

AHEALTH

Apex Healthcare Berhad
RM2.85-15.2%3.0%RM2.0bRM2.71PE5.2xE-51.2%8.8%

KOTRA

Kotra Industries Berhad
RM4.68-1.9%-14.9%RM694.1mRM5.50PE12.4xE8.3%5.4%

YSPSAH

Y.S.P. Southeast Asia Holding Berhad
RM2.552.0%3.7%RM361.7mn/aPE9.7xn/a4.3%

RHONEMA

Rhone Ma Holdings Berhad
RM0.670%-7.0%RM147.1mn/aPE12.1xE1.1%3.0%

PLABS

PeterLabs Holdings Berhad
RM0.200%2.6%RM53.7mn/aPE15.6xn/a2.1%

DPHARMA

Duopharma Biotech Berhad
RM1.261.6%-14.3%RM1.2bRM1.48PE23xE21.0%1.8%

MGRC

Malaysian Genomics Resource Centre Berhad
RM0.44-2.2%-17.8%RM60.4mn/aPS6.3xn/a0%
Page 1 of 1
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.